An Observational Study Evaluating the Safety, Tolerability, and Efficacy of Treatment of SM04690 or Placebo Previously Injected in the Target Knee Joint of Subjects With Moderately to Severely Symptomatic Osteoarthritis
Public ClinicalTrials.gov record NCT02951026. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 3, Multicenter, Observational Long-term Study Evaluating the Safety, Tolerability, and Efficacy of Treatment of SM04690 or Placebo Previously Injected in the Target Knee Joint of Subjects With Moderately to Severely Symptomatic Osteoarthritis
Study identification
- NCT ID
- NCT02951026
- Recruitment status
- Completed
- Study type
- Observational
- Phase
- Not listed
- Lead sponsor
- Biosplice Therapeutics, Inc.
- Industry
- Enrollment
- 703 participants
Conditions and interventions
Conditions
Interventions
- Not applicable (no therapy is administered as part of this study) Other
Other
Eligibility (public fields only)
- Age range
- 40 Years to 80 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Sep 18, 2016
- Primary completion
- Oct 30, 2019
- Completion
- Oct 30, 2019
- Last update posted
- Apr 16, 2020
2016 – 2019
United States locations
- U.S. sites
- 62
- U.S. states
- 27
- U.S. cities
- 62
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Research Site | Birmingham | Alabama | — | — |
| Research Site | Oro Valley | Arizona | — | — |
| Research Site | Phoenix | Arizona | — | — |
| Research Site | Tucson | Arizona | — | — |
| Research Site | Canoga Park | California | — | — |
| Research Site | Carmichael | California | — | — |
| Research Site | Cerritos | California | — | — |
| Research Site | El Cajon | California | — | — |
| Research Site | Gold River | California | — | — |
| Research Site | La Mesa | California | — | — |
| Research Site | Palm Springs | California | — | — |
| Research Site | Rancho Mirage | California | — | — |
| Research Site | Sacramento | California | — | — |
| Research Site | San Diego | California | — | — |
| Research Site | San Marcos | California | — | — |
| Research Site | Spring Valley | California | — | — |
| Research Site | Boulder | Colorado | — | — |
| Research Site | Stamford | Connecticut | — | — |
| Research Site | Trumbull | Connecticut | — | — |
| Research Site | Waterbury | Connecticut | — | — |
| Research Site | Clearwater | Florida | — | — |
| Research Site | Coral Gables | Florida | — | — |
| Research Site | DeLand | Florida | — | — |
| Research Site | Edgewater | Florida | — | — |
| Research Site | Lauderdale Lakes | Florida | — | — |
| Research Site | Miami | Florida | — | — |
| Research Site | Marietta | Georgia | — | — |
| Research Site | Woodstock | Georgia | — | — |
| Research Site | Chicago | Illinois | — | — |
| Research Site | Newton | Kansas | — | — |
| Research Site | Wichita | Kansas | — | — |
| Research Site | Lexington | Kentucky | — | — |
| Research Site | Frederick | Maryland | — | — |
| Research Site | Boston | Massachusetts | — | — |
| Research Site | Troy | Michigan | — | — |
| Research Site | City of Saint Peters | Missouri | — | — |
| Research Site | Kansas City | Missouri | — | — |
| Research Site | St Louis | Missouri | — | — |
| Research Site | Lincoln | Nebraska | — | — |
| Research Site | Las Vegas | Nevada | — | — |
| Research Site | Albuquerque | New Mexico | — | — |
| Research Site | Orchard Park | New York | — | — |
| Research Site | Rochester | New York | — | — |
| Research Site | Charlotte | North Carolina | — | — |
| Research Site | High Point | North Carolina | — | — |
| Research Site | Raleigh | North Carolina | — | — |
| Research Site | Salisbury | North Carolina | — | — |
| Research Site | Cincinnati | Ohio | — | — |
| Research Site | Cleveland | Ohio | — | — |
| Research Site | Duncansville | Pennsylvania | — | — |
| Research Site | Philadelphia | Pennsylvania | — | — |
| Research Site | Charleston | South Carolina | — | — |
| Research Site | Mt. Pleasant | South Carolina | — | — |
| Research Site | Rapid City | South Dakota | — | — |
| Research Site | Knoxville | Tennessee | — | — |
| Research Site | Austin | Texas | — | — |
| Research Site | Bedford | Texas | — | — |
| Research Site | Houston | Texas | — | — |
| Research Site | San Angelo | Texas | — | — |
| Research Site | Layton | Utah | — | — |
| Research Site | Arlington | Virginia | — | — |
| Research Site | Charlottesville | Virginia | — | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02951026, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Apr 16, 2020 · Synced Jul 23, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT02951026 live on ClinicalTrials.gov.